Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
16 Syndrome in a Patient With Multiple Sclerosis.
Neurogenic detrusor overactivity: an update on management options.
BAb and MxA as functional biomarkers in routine clinical laboratories for the determination of anti-IFN-beta antibodies and their bioactivity levels in Multiple Sclerosis patients.
Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.
Paraneoplastic neuromyelitis optica associated with ANNA-1 antibodies in invasive thymoma.
Effective communication at the point of multiple sclerosis diagnosis.
Oligodendroglia in cortical multiple sclerosis lesions decrease with disease progression, but regenerate after repeated experimental demyelination.
Accurate GM atrophy quantification in MS using lesion-filling with co-registered 2D lesion masks.
Mode of action and clinical studies with fumarates in multiple sclerosis.
[Multiple sclerosis and occupational exposures: results of an explorative study].
Apolipoprotein E mediation of neuro-inflammation in a murine model of multiple sclerosis.
Neuromyelitis Optica with NMO-IgG/Anti-AQP4 Antibody Positive: First Case Reported from Uttarakhand India.
Correlation between brain volume change and T2 relaxation time induced by dehydration and rehydration: Implications for monitoring atrophy in clinical studies.
High-Content Phenotypic Screening and Triaging Strategy to Identify Small Molecules Driving Oligodendrocyte Progenitor Cell Differentiation.
Relationship between urodynamic findings and sexual function in multiple sclerosis patients with lower urinary tract dysfunction.
Impact of anger on the health-related quality of life of multiple sclerosis patients.
Prolactin: A versatile regulator of inflammation and autoimmune pathology.
Multiple sclerosis: Cannabis use is associated with deleterious brain changes in patients with multiple sclerosis.
Progressive multifocal leukoencephalopathy: Dot-shaped inclusions and virus-host interactions.
Subcutaneous immunoglobulin in CIDP and MMN: a different long-term clinical response?
Validation and cross-cultural adaptation of sexual dysfunction modified scale in multiple sclerosis for Brazilian population.
Characterisation of a Novel Anti-CD52 Antibody with Improved Efficacy and Reduced Immunogenicity.
Acute and Chronic Management of Neuromyelitis Optica Spectrum Disorder.
Sex differences in neurodevelopmental and neurodegenerative disorders: Focus on microglial function and neuroinflammation during development.
Multiple Sclerosis and Risk of Infection-Related Hospitalization and Death in US Veterans.
Pages
« first
‹ previous
…
489
490
491
492
493
494
495
496
497
…
next ›
last »